Mitogen- and stress-activated protein kinase 1 is critical for interleukin-1-induced, CREB-mediated, c-fos gene expression in keratinocytes

Oncogene

Volumn 25, Issue 32, 2006, Pages 4449-4457

  Schiller, M ^a,b   Bohm M ^b   Dennler, S ^a   Ehrchen, J M ^b   Mauviel, A ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

c fos; cAMP; CREB; Interleukin 1; MAP kinases; PKA

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; PROSTAGLANDIN SYNTHASE; PROTEIN C FOS; SERINE; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME REGULATION; GENE INDUCTION; HOMEOSTASIS; HUMAN; HUMAN CELL; KERATINOCYTE; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; HUMANS; INTERLEUKIN-1; KERATINOCYTES; PROTO-ONCOGENE PROTEINS C-FOS; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SIGNAL TRANSDUCTION;

EID: 33746476299     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209479     Document Type: Article

References (38)

1. Ahn S, Olive M, Aggarwal S, Krylov D, Ginty DD, Vinson C. (1998). Mol Cell Biol 18: 967-977.
2. Andrisani OM. (1999). Crit Rev Eukaryot Gene Expr 9: 19-32.
3. Angel P, Szabowski A, Schorpp-Kistner M. (2001). Oncogene 20: 2413-2423.
4. Braddock M, Quinn A. (2004). Nat Rev Drug Discov 3: 330-339.
5. Caivano M, Cohen P. (2000). J Immunol 164: 3018-3025.
6. Cavigelli M, Dolfi F, Claret FX, Karin M. (1995). EMBO J 14: 5957-5964.
7. Chang L, Karin M. (2001). Nature 410: 37-40.
8. Crofford LJ, Wilder RL, Ristimaki AP, Sano H, Remmers EF, Epps HR et al. (1994). J Clin Invest 93: 1095-1101.
9. Dayer JM. (2003). Rheumatology (Oxford) 42(Suppl 2): ii3-ii10.
10. Deak M, Clifton AD, Lucocq LM, Alessi DR. (1998). EMBO J 17: 4426-4441.
11. Dinarello CA. (2002). Clin Exp Rheumatol 20: S1-S13.
12. Gonzalez GA, Montminy MR. (1989). Cell 59: 675-680.
13. Hagiwara M, Brindle P, Harootunian A, Armstrong R, Rivier J, Vale W et al. (1993). Mol Cell Biol 13: 4852-4859.
14. Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L et al. (2001). J Clin Invest 108: 73-81.
15. Hazzalin CA, Cuenda A, Cano E, Cohen P, Mahadevan LC. (1997). Oncogene 15: 2321-2331.
16. Hazzalin CA, Mahadevan LC. (2002). Nat Rev Mol Cell Biol 3: 30-40.
17. Karin M. (1996). Philos Trans R Soc London B 351: 127-134.
18. Karin M, Liu Z, Zandi E. (1997). Curr Opin Cell Biol 9: 240-246.
19. Kumar S, Votta BJ, Rieman DJ, Badger AM, Gowen M, Lee JC. (2001). J Cell Physiol 187: 294-303.
20. Livak KJ, Schmittgen TD. (2001). Methods 25: 402-408.
21. Luger TA, Schwarz T. (1990). J Invest Dermatol 95: 100S-104S.
22. Maier JA, Hla T, Maciag T. (1990). J Biol Chem 265: 10805-10808.
23. Mauviel A, Chen Y, Dong W, Evans CH, Uitto J. (1993). Curr Biol 3: 822-831.
24. Podolsky DK. (1997). J Gastroenterol 32: 122-126.
25. Price MA, Hill C, Treisman R. (1996). Philos Trans R Soc London B 351: 551-559.
26. Ramirez S, Ait-Si-Ali S, Robin P, Trouche D, Harel-Bellan A. (1997). J Biol Chem 272: 31016-31021.
27. Robertson LM, Kerppola TK, Vendrell M, Luk D, Smeyne RJ, Bocchiaro C et al. (1995). Neuron 14: 241-252.
28. Schuck S, Soloaga A, Schratt G, Arthur JS, Nordheim A. (2003). BMC Mol Biol 4: 6.
29. Shaulian E, Karin M. (2002). Nat Cell Biol 4: E131-E136.
30. Song KS, Lee WJ, Chung KC, Koo JS, Yang EJ, Choi JY et al. (2003). J Biol Chem 278: 23243-23250.
31. Strniskova M, Barancik M, Ravingerova T. (2002). Gen Physiol Biophys 21: 231-255.
32. Treisman R. (1995). EMBO J 14: 4905-4913.
33. Vincenti MP, White LA, Schroen DJ, Benbow U, Brinckerhoff CE. (1996). Crit Rev Eukaryot Gene Expr 6: 391-411.
34. Wang ZQ, Liang J, Schellander K, Wagner EF, Grigoriadis AE. (1995). Cancer Res 55: 6244-6251.
35. West-Mays JA, Strissel KJ, Sadow PM, Fini ME. (1995). Proc Natl Acad Sci USA 92: 6768-6772.
36. Westermarck J, Kahari VM. (1999). FASEB J 13: 781-792.
37. Weston CR, Davis RJ. (2002). Curr Opin Genet Dev 12: 14-21.
38. Yang SH, Sharrocks AD, Whitmarsh AJ. (2003). Gene 320: 3-21.